Marco A. Braga
Universidade Estadual de Maringá
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marco A. Braga.
Tissue Antigens | 2008
Danilo Santana Alessio Franceschi; Priscila Saamara Mazini; Cristiane Conceição Chagas Rudnick; Ana Maria Sell; Luiza Tamie Tsuneto; F. C. de Melo; Marco A. Braga; Paulo R. Peixoto; Jeane Eliete Laguila Visentainer
The aim of this study was to investigate the role of killer cell immunoglobulin-like receptor (KIR) genes in leprosy immunopathogenesis. Genotyping of KIR and human leukocyte antigen (HLA) genes was performed by polymerase chain reaction with sequence-specific oligonucleotide probes in 165 leprosy patients. Both activating KIR2DS2 and KIR2DS3 frequencies were higher in tuberculoid leprosy (TT) patients than in lepromatous leprosy (LL) patients, and the inhibitory KIR with its ligand, KIR2DL1-C2/C2, was elevated in TT patients in comparison to all other leprosy subgroups and controls. However, a negative association between KIR2DL3-C1 and KIR2DL3-C1/C1 and the TT group was identified. Borderline patients exhibited a higher frequency of KIR3DL2-A3/11 than the controls and LL patients, and a lower frequency of KIR2DL1-C2 than the controls and TT subgroup. Some KIR-HLA genotypes could be associated to the development of clinical forms of leprosy and should be investigated further.
Revista Da Sociedade Brasileira De Medicina Tropical | 2009
Daniela Maira Cardozo; Gláucia Andréia Soares Guelsin; Samaia Laface Clementino; Fabiano Cavalcante de Melo; Marco A. Braga; Cleonice de Souza; Ricardo Alberto Moliterno; Jeane Eliete Laguila Visentainer
The objective of this study was to standardize a method for extracting high-quality DNA from samples of coagulated blood. Forty-eight samples of human coagulated blood were used for DNA extraction by means of the EZ-DNA commercial kit (Biological Industries, Beit Haemek, Israel), the Neoscience column kit (One Lambda Inc., San Diego, CA, USA) and a modified salting-out method. Only the salting-out method was able to extract high concentrations of DNA (mean, 180 ng/(1/4)microl), which were measured using the Qubit fluorescence detector (Invitrogen, USA). This method enabled amplification of HLA (human leukocyte antigen) genes using the Luminex PCR-SSO (polymerase chain reaction - sequence-specific oligonucleotide) technology, which demands good quality DNA, and amplification of KIR (killer-cell immunoglobulin-like receptor) genes using an in-house PCR-SSP (polymerase chain reaction - sequence-specific primer) technique, which demands a specific concentration of DNA (10 ng/(1/4)microl). We concluded that the modified salting-out technique was very efficient, simple and fast for DNA extraction from human coagulated blood samples, with the aim of genotyping the HLA and KIR genes.
Haemophilia | 2012
M. F. de Barros; Juliana Curi Martinichen Herrero; Ana Maria Sell; F. C. de Melo; Marco A. Braga; C. B. Pelissari; José Machado; S. De Souza Schiller; L. De Souza Hirle; Jeane Eliete Laguila Visentainer
Summary. Congenital haemophilia A is a chromosome‐linked recessive disorder caused by the deficiency or reduction of factor VIII (FVIII) pro‐coagulant activity. During treatment, some patients develop alloantibodies (FVIII inhibitors) that neutralize the action of exogenously administered FVIII. Currently, the presence of these inhibitors is the most serious adverse event found in replacement therapy. Some studies have suggested that genetic factors influence the development of the FVIII coagulation inhibitors. To identify the class I and II alleles that may be influencing the formation of inhibitors in severe haemophilic patients. Genotyping of the class I (HLA‐A, ‐B and ‐C) and class II (HLA‐DRB1, ‐DQA1 and ‐DQB1) alleles of 122 patients with severe haemophilia A, including 36 who had developed antibodies to factor VIII, was performed. After the comparison of the group without inhibitors and the group with inhibitors, HLA‐C*16 [Odds ratio (OR) = 7.73; P = 0.0092] and HLA‐DRB1*14 (OR = 4.52; P = 0.0174) were found to be positively associated with the formation of the inhibitors. These results confirm that HLA alleles are involved in inhibitor production and could be used as a tool for recognition of groups at high risk of possible inhibitor development in Southern Brazilian haemophilic patients.
International Journal of Immunogenetics | 2012
W. Sergio do Sacramento; Priscila Saamara Mazini; Danilo A.S. Franceschi; F. C. de Melo; Marco A. Braga; Ana Maria Sell; Luiza Tamie Tsuneto; J. E. Laguila Visentainer
Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which mainly affects the skin and nervous system. The disease has several clinical forms. This study investigated the MICA and HLA‐B genes in 223 samples from leprosy patients and 201 samples from healthy individuals matched for age, gender and ethnical background. Of the patients, 153 had multibacillary, 45 paucibacillary and 25 indeterminate leprosy. The aim of this case–control study was to assess whether the MICA alleles influence susceptibility for leprosy or affect the subtype of the disease in a population of southern Brazil. There were significant differences in frequencies of the MICA*027 allele (4.7% vs 1.8%, P‐value = 0.01, OR = 0.37; 95% CI = 0.16–0.85) between leprosy patients and controls, and of the MICA*010 (4.5% vs 1.6%, P‐value = 0.05, OR = 0.35, 95% CI = 0.13–0.97) and MICA*027 alleles (4.7% vs 1.3%, P‐value = 0.01; OR = 0.27; 95% CI = 0.09–0.79) between multibacillary leprosy patients and the control group. There were no significant differences in the frequency of MICA alleles between paucibacillary leprosy patients and controls. Thus, the MICA*027 allele is associated with a protective effect for leprosy per se, while the MICA*010 and MICA*027 alleles are associated with protection against multibacillary leprosy, the most severe clinical subtype.
Journal of Clinical Laboratory Analysis | 2014
Amanda Vansan Marangon; Jeane Eliete Laguila Visentainer; Gláucia Andréia Soares Guelsin; Samaia Laface Clementino; Cristiane Conceição Chagas Rudnick; Fabiano Cavalcante de Melo; Marco A. Braga; Ana Maria Sell
The aim of this study was to investigate the distribution of full‐length and deleted variants of KIR2DS4 in a population of southern Brazil and compare the results with other populations, as well as comparing two techniques, PCR‐SSP and PCR‐SSO, for typing of variants.
Human Immunology | 2018
Josiane Bazzo de Alencar; Joana Maira Valentini Zacarias; Barbara Leticia da Silva Guedes de Moura; Marco A. Braga; Jeane Eliete Laguila Visentainer; Ana Maria Sell
In order to investigate killer immunoglobulin-like receptors (KIR) and their ligands, human leukocyte antigen (HLA), diversity in the Brazilian population influenced by migrations, unrelated Brazilian Japanese descendants were selected and genotyped for the KIR genes and HLA class I allele groups. Genetic heterogeneity in Brazil Paraná Japanese was observed for KIR genes, whose frequency distributions demonstrated similarity with mixed Brazilian populations and with the Japanese population, suggesting gene flow. The data contributed to the identification of the genetic constitution of the Brazilian population influenced by immigrations and two new genotypes were defined.
Acta Scientiarum. Health Science | 2014
Rejane Cristina Ribas-Silva; Adriana Danmvolf Ribas; Luciana Borges Giarola; Marina Raduy Botelho; Marco A. Braga; Sueli Donizete Borelli
Human Immunology | 2011
Willian Sergio do Sacramento; Luciana Ribeiro Jarduli; Priscila Saamara Mazini; Danilo A.S. Franceschi; Fabiano Cavalcante de Melo; Marco A. Braga; Ana Maria Sell; Luiza Tamie Tsuneto; Jeane Eliete Laguila Visentainer
Human Immunology | 2010
Morgana Ferreira de Barros; Juliana Curi Martinichen Herrero; Ana Maria Sell; Fabiano Cavalcante de Melo; Marco A. Braga; Cinthia B. Pelissari; Júlio Machado; Sandra de Souza Schiller; Loide Souza Hirle; Jeane Eliete Laguila Visentainer
Archive | 2009
Daniela Maira Cardozo; Gláucia Andréia Soares Guelsin; Samaia Laface Clementino; Fabiano Cavalcante de Melo; Marco A. Braga; Cleonice de Souza; Ricardo Alberto Moliterno; Jeane Eliete; Laguila Visentainer